IRIS
METRA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 32.496
NA - Nord America 23.592
AS - Asia 9.150
Continente sconosciuto - Info sul continente non disponibili 3.023
SA - Sud America 751
AF - Africa 186
OC - Oceania 26
Totale 69.224
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.994
RU - Federazione Russa 17.827
IT - Italia 11.192
SG - Singapore 2.844
CN - Cina 2.832
FR - Francia 2.226
BD - Bangladesh 1.215
CA - Canada 719
HK - Hong Kong 714
VN - Vietnam 646
BR - Brasile 431
GB - Regno Unito 328
IN - India 229
DE - Germania 215
JM - Giamaica 176
CR - Costa Rica 145
NL - Olanda 137
MX - Messico 110
HN - Honduras 89
AR - Argentina 88
RO - Romania 83
ES - Italia 74
ID - Indonesia 73
IQ - Iraq 72
SE - Svezia 70
JP - Giappone 69
NI - Nicaragua 64
TR - Turchia 63
FI - Finlandia 59
PL - Polonia 58
CO - Colombia 57
EC - Ecuador 52
PH - Filippine 52
SV - El Salvador 52
ZA - Sudafrica 52
TT - Trinidad e Tobago 51
VE - Venezuela 49
PK - Pakistan 46
GT - Guatemala 44
MY - Malesia 43
PR - Porto Rico 41
SA - Arabia Saudita 40
AT - Austria 30
IE - Irlanda 26
TH - Thailandia 26
MD - Moldavia 25
CL - Cile 24
DZ - Algeria 24
UA - Ucraina 22
BB - Barbados 19
AU - Australia 18
EG - Egitto 18
IL - Israele 18
NP - Nepal 18
PE - Perù 18
JO - Giordania 17
MA - Marocco 17
AE - Emirati Arabi Uniti 16
CH - Svizzera 16
KE - Kenya 16
UZ - Uzbekistan 16
LT - Lituania 15
PY - Paraguay 15
CW - ???statistics.table.value.countryCode.CW??? 14
PT - Portogallo 14
TW - Taiwan 14
BS - Bahamas 13
KR - Corea 13
TN - Tunisia 13
BE - Belgio 11
GR - Grecia 10
IR - Iran 10
NG - Nigeria 10
RS - Serbia 10
BZ - Belize 9
DO - Repubblica Dominicana 9
GP - Guadalupe 9
CU - Cuba 8
SC - Seychelles 7
AZ - Azerbaigian 6
BO - Bolivia 6
CI - Costa d'Avorio 6
CY - Cipro 6
EE - Estonia 6
LB - Libano 6
OM - Oman 6
UY - Uruguay 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
FJ - Figi 5
GD - Grenada 5
HT - Haiti 5
SI - Slovenia 5
AG - Antigua e Barbuda 4
BH - Bahrain 4
BM - Bermuda 4
DK - Danimarca 4
ET - Etiopia 4
KY - Cayman, isole 4
MM - Myanmar 4
Totale 66.115
Salva come PNG Salva come JPEG
Città #
Moscow 4.053
Ashburn 3.833
Council Bluffs 2.679
Milan 2.262
Lauterbourg 1.752
San Jose 1.477
Phoenix 1.222
Rome 1.023
Singapore 835
New York 800
Hong Kong 698
Naples 592
Santa Clara 518
Los Angeles 420
Miano 419
Beijing 405
North Bergen 402
Dallas 315
Bologna 269
Turin 265
Ho Chi Minh City 208
Orem 206
Atlanta 187
Florence 177
Bari 174
Catania 166
Brescia 159
Hanoi 156
Palermo 152
Omaha 133
Chicago 128
Genoa 121
San José 112
Toronto 111
Montreal 110
Buffalo 103
Brooklyn 99
Kingston 97
Denver 94
Cagliari 88
San Francisco 82
Chennai 80
Las Vegas 80
Modena 71
Padua 71
Figino 70
Philadelphia 70
Verona 70
Frankfurt am Main 66
London 66
Miami 64
Managua 61
Venice 60
Shanghai 58
Nuremberg 57
Houston 56
Boston 51
Queens 51
Tokyo 50
Princeton 49
San Salvador 49
The Bronx 49
Manchester 48
Seattle 48
São Paulo 48
Da Nang 47
Mexico City 44
Pescara 44
Perugia 43
Mumbai 42
Afragola 40
Charlotte 39
Hefei 38
Warsaw 38
Washington 37
Lappeenranta 36
Boardman 35
Parma 35
Paris 34
Tegucigalpa 34
Newark 31
Amsterdam 30
Guatemala City 30
Tampa 30
Detroit 29
Pisa 29
Baghdad 28
Columbus 28
Haiphong 28
Monza 28
Johannesburg 26
Reggio Emilia 26
Taranto 26
Cincinnati 25
Pasadena 25
Calgary 24
Cleveland 24
Jacksonville 24
Rimini 24
Hangzhou 23
Totale 29.669
Salva come PNG Salva come JPEG
Nome #
2024 update in heart failure 409
Global epidemiology of heart failure 251
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias 238
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation 228
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 200
Impact analysis of heart failure across European countries: an ESC-HFA position paper 185
Lactate Values and Mortality in Patients With Cardiogenic Shock: Insights From the Altshock-2 Registry 185
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry 183
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 170
Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the ESC 168
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair 166
H2FPEF and HFA-PEFF scores performance and the additional value of cardiac structure and function in patients with atrial fibrillation 142
Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document 140
Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine--short version 124
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 115
Blood Pressure Drops During Hospitalization for Acute Heart Failure Treated With Serelaxin: A Patient-Level Analysis of 4 Randomized Controlled Trials 114
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 114
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 113
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI 105
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 103
Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry 102
The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysis 101
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) 100
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves 99
Prognostic Value of Pre-operative Atrial Fibrillation in Patients with Secondary Mitral Regurgitation Undergoing MitraClip Implantation 99
Transcatheter Edge-To-Edge Repair in COAPT-ineligible Patients: Incidence and Predictors of 2-year Good Outcome 98
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart 97
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 97
Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score 96
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 96
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 95
Management of cardiac sarcoidosis A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC 93
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 92
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 92
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 91
Tricuspid Regurgitation Disease Stages and Treatment Outcomes After Transcatheter Tricuspid Valve Repair 91
Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry 90
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 89
Varicella zoster virus and cardiovascular diseases 88
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 88
The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS) 86
Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair 85
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology 82
Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis 82
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies 80
The prognostic value of the Dandel's index in patients undergoing tricuspid transcatheter edge-to-edge repair 80
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial 80
Organ perfusion pressure predicts outcomes in cardiogenic shock patients 79
Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities? 77
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 77
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 76
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 76
Right Ventricular–Pulmonary Artery Coupling in Tricuspid Regurgitation: Prognostic Value and Impact of Treatment Strategy 76
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 76
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release 74
Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis 74
ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes 74
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension 73
Percutaneous Edge-to-Edge Mitral Valve Repair: Beyond the Left Heart 72
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 72
Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction 72
Dynamic cardiomyoplasty as an effective therapy for dilated cardiomyopathy 71
Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC 71
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 70
Differences in biomarkers and molecular pathways according to age for patients with HFrEF 70
The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association 70
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 69
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper 68
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 67
TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention 67
COVID myocarditis: a review of the literature 66
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 66
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 66
THE INTERPLAY BETWEEN CARDIOLOGY AND DIABETOLOGY: A RENEWED COLLABORATION TO OPTIMIZE CARDIOVASCULAR PREVENTION AND HEART FAILURE MANAGEMENT 66
Soluble guanylate cyclase: a potential therapeutic target for heart failure 65
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 65
Heart failure: an update from the last years and a look at the near future 64
A Critical Appraisal of Short-Term End Points in Acute Heart Failure Clinical Trials 64
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies 64
Heart Failure Association of the European Society of Cardiology update on sodium–glucose co-transporter 2 inhibitors in heart failure 64
The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair 64
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 63
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study 63
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 63
Current Treatment of Heart Failure with Preserved Ejection Fraction 63
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 62
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 62
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 62
Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak 61
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 61
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 60
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 60
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 - epidemiology, pathophysiology, and diagnosis 60
Aortopathies: From Etiology to the Role of Arterial Stiffness 60
Linee guida ESC 2021 per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico elaborate dalla Task Force per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico della Società Europea di Cardiologia (ESC) con il contributo straordinario della Heart Failure Association (HFA) dell’ESC 59
Transcatheter treatment of chronic mitral regurgitation with the MitraClip system: an Italian consensus statement 59
Mitral regurgitation evolution after transcatheter tricuspid valve interventions - A sub-analysis of the TriValve registry 58
Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance 58
Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device-supported patients for the non-left ventricular assist device specialist healthcare provider: Part 2: at the emergency department 58
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 58
Totale 9.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 430.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 430.061
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 3 0 3 2 0 2 0 1 2
2022/2023113 35 16 5 1 3 12 11 12 5 2 2 9
2023/2024134 19 4 12 10 11 13 3 16 0 6 16 24
2024/2025470 42 9 9 19 9 40 57 86 87 51 27 34
2025/202640.787 101 118 119 225 375 5.117 5.418 4.137 18.131 3.540 1.900 1.606
2026/202727.691 2.882 5.471 4.852 14.486 0 0 0 0 0 0 0 0
Totale 69.224